-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Ironwood Pharmaceuticals, Raises Price Target to $10

Benzinga·02/26/2026 14:48:27
Listen to the news
Citizens analyst Jason N. Butler maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Market Outperform and raises the price target from $8 to $10.